Fred Alger Management »

Avalo Therapeutics Ord shares owned by Fred Alger Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 80k 18.16

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
Alphabet Inc. Class C Equity (GOOG)
Meta Platforms Inc Class A Equity (META)
Nebius Group N.V. Class A Equity (NBIS)
Broadcom Equity (AVGO)
Western Digital Corporation Equity (WDC)
Tesla Equity (TSLA)
AppLovin Corp. Class A Equity (APP)
Qxo Equity (QXO)
Talen Energy Corp Equity (TLN)
Natera Equity (NTRA)
GE Vernova Equity (GEV)

View all positions for Fred Alger Management

Top funds holding Avalo Therapeutics Ord

BVF
Logos Global Management
Nantahala Capital Management
UBS Group
Affinity Asset Advisors
Point72 Asset Management
Caligan Partners
Millennium Management
Vanguard Group
TCG Crossover Management
Balyasny Asset Management
Vanguard Capital Management
RA Capital Management
Bank of America Corporation
Ikarian Capital

View all funds holding Avalo Therapeutics Ord